Skip to main content
Clinical Trials/JPRN-UMIN000044246
JPRN-UMIN000044246
Completed
N/A

An open-label, unblinded, exploratory study to evaluate the eye movement in Parkinson disease patients - ExSEM-PD

Department of Neurology Juntendo University School of Medicine0 sites20 target enrollmentMay 18, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
Parkinson disease
Sponsor
Department of Neurology Juntendo University School of Medicine
Enrollment
20
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The MDS-UPDRS Part III score of PD motor symptoms, the ON/OFF score of the patient symptom diary, and the L-dopa blood concentration showed similar trends to the blink frequency. Furthermore, by extracting various parameters such as blink duration and confidence from the blink information and applying machine learning, we constructed a model to estimate clinical symptoms at the same point in time from 3 minutes of blink data. UPDRS Part III score in real time.

Registry
who.int
Start Date
May 18, 2021
End Date
March 31, 2022
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Department of Neurology Juntendo University School of Medicine

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\.Atypical Parkinsonism syndromes 2\.Dementia or at high risk of it (Mini Mental State Examination (MMSE) score \< \= 20\) 3\.Contraindicated for concomitant medications (L\-DOPA / carbidopa) 4\.Hypersensitivity to concomitant medications (L\-DOPA / carbidopa) and/or their ingredients 5\.Co\-existing psychiatric disease (e.g., depression, bipolar disorder or schizophrenia) and/or clinically significant complications (e.g., cerebrovascular accident, heart disease, chronic respiratory disease, uncontrolled hypertension and diabetes) 6\.History of psychiatric disease (e.g., depression, bipolar disorder or schizophrenia) and/or device\-aided therapies (i.e., GPi pallidotomy, thalamotomy, and deep brain stimulation) 7\.Those who are judged by the principal investigator to be inappropriate as research subjects

Outcomes

Primary Outcomes

Not specified

Similar Trials